Chanelle Pharmaceuticals Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Chanelle Pharmaceuticals and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 730 Chanelle Pharmaceuticals employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Chanelle Pharmaceuticals has purchased the following applications: In-House ATS for Applicant Tracking System in 2011, Equiniti Perito Case Management for Case Management in 2018, Microsoft Azure CDN for Content Delivery Network in 2019 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Chanelle Pharmaceuticals is running and its propensity to invest more and deepen its relationship with In-House Applications , Equiniti Group , Microsoft or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Chanelle Pharmaceuticals revenues, which have grown to $158.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Chanelle Pharmaceuticals intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.